Protara Therapeutics Inc (TARA)
2.91
+0.02
(+0.69%)
USD |
NASDAQ |
May 03, 16:00
2.89
-0.02
(-0.69%)
After-Hours: 20:00
Protara Therapeutics Max Drawdown (5Y): 99.25% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.25% |
| March 31, 2024 | 99.25% |
| February 29, 2024 | 99.25% |
| January 31, 2024 | 99.25% |
| December 31, 2023 | 99.25% |
| November 30, 2023 | 99.25% |
| October 31, 2023 | 99.19% |
| September 30, 2023 | 98.91% |
| August 31, 2023 | 98.76% |
| July 31, 2023 | 98.76% |
| June 30, 2023 | 98.76% |
| May 31, 2023 | 98.76% |
| April 30, 2023 | 98.76% |
| March 31, 2023 | 98.76% |
| February 28, 2023 | 98.76% |
| January 31, 2023 | 98.76% |
| December 31, 2022 | 98.76% |
| November 30, 2022 | 98.76% |
| October 31, 2022 | 98.76% |
| September 30, 2022 | 98.76% |
| August 31, 2022 | 98.76% |
| July 31, 2022 | 98.76% |
| June 30, 2022 | 98.76% |
| May 31, 2022 | 98.76% |
| April 30, 2022 | 98.76% |
| Date | Value |
|---|---|
| March 31, 2022 | 98.76% |
| February 28, 2022 | 98.76% |
| January 31, 2022 | 98.76% |
| December 31, 2021 | 98.76% |
| November 30, 2021 | 98.76% |
| October 31, 2021 | 98.76% |
| September 30, 2021 | 98.76% |
| August 31, 2021 | 98.76% |
| July 31, 2021 | 98.76% |
| June 30, 2021 | 98.76% |
| May 31, 2021 | 98.76% |
| April 30, 2021 | 98.76% |
| March 31, 2021 | 98.76% |
| February 28, 2021 | 98.76% |
| January 31, 2021 | 98.76% |
| December 31, 2020 | 98.76% |
| November 30, 2020 | 98.76% |
| October 31, 2020 | 98.76% |
| September 30, 2020 | 98.76% |
| August 31, 2020 | 98.76% |
| July 31, 2020 | 98.76% |
| June 30, 2020 | 98.76% |
| May 31, 2020 | 98.76% |
| April 30, 2020 | 98.76% |
| March 31, 2020 | 98.76% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.22%
Minimum
May 2019
99.25%
Maximum
Nov 2023
98.79%
Average
98.76%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| AngioDynamics Inc | 82.98% |
| Regulus Therapeutics Inc | 99.80% |
| Bio-Path Holdings Inc | 99.48% |
| Outset Medical Inc | -- |
| AN2 Therapeutics Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -51.02 |
| Beta (5Y) | 1.801 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 102.7% |
| Historical Sharpe Ratio (5Y) | -0.3012 |
| Historical Sortino (5Y) | -0.8983 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.68% |